Related Experiment Videos
Pharmacologic management of obsessive-compulsive disorder
C W Jackson1, W A Morton, R B Lydiard
1Department of Hospital Pharmacy Practice and Administration, Medical University of South Carolina, Charleston 29425.
Southern Medical Journal
|March 1, 1994
Summary
Selective serotonin reuptake inhibitors (SSRIs) effectively treat obsessive-compulsive disorder (OCD) by targeting neurotransmitter imbalances. Pharmacotherapy significantly reduces symptoms and enhances patients
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Obsessive-compulsive disorder (OCD) presents as intrusive thoughts and anxiety-reducing rituals.
- Evidence links OCD to dysregulation in serotonin and dopamine neurotransmission.
Purpose of the Study:
- To review the efficacy of pharmacotherapy in treating obsessive-compulsive disorder.
- To explore the role of serotonergic agents in managing OCD symptoms.
Main Methods:
- Review of early studies involving clomipramine and other serotonin-specific reuptake inhibitors (SSRIs).
- Analysis of clinical trial findings for various serotonergic agents.
Main Results:
- Drugs inhibiting serotonin reuptake demonstrate clear benefits in OCD treatment.
- Pharmacotherapy may be more effective for obsessive thoughts than compulsive rituals.
- Effective treatment significantly decreases obsessive-compulsive symptoms.
Conclusions:
- Serotonergic agents are beneficial in managing obsessive-compulsive disorder.
- Pharmacotherapy improves patient quality of life by reducing OCD symptoms.